The prolific country artist has battled Charcot-Marie-Tooth disease for over a decade. Here's what to know about the ...
CMTA invests $423K in genomic research to close CMT diagnostic gaps, advance gene discovery, and expand the GENESIS platform, driving progress toward a cure. Expanding this resource isn’t just ...
In 2022, HNF launched the CMT Genie, a patient-initiated genetic testing program to support genetic diagnosis by offering patients virtual genetic counseling with an option to obtain a ...
SEOUL, South Korea--(BUSINESS WIRE)--ENCell, a leading biopharmaceutical company for cell and gene therapy CDMO and novel drug development, announced today that its investigational drug EN001 has been ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果